Cytosorbents (CTSO) Misses Q1 EPS by 4c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• L3Harris CEO steps down amid conduct review, shares drop